CClinicalTrials.gg
Not yet recruitingNCT03705598Updated Aug 6, 2026

Tai Chi Intervention for Geriatric Pain Syndrome

An interventional study of Light physical exercise and Tai Chi in Chronic Pain and Falls, sponsored by University of Massachusetts, Boston. Not yet recruiting. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by University of Massachusetts, Boston · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
266
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Accumulating evidence supports that more pain, whether measured by number of pain sites or pain severity, is associated with poorer cognitive function and mobility, and fall risk in older persons. Tai Chi which holistically integrates physical and cognitive functions offers the possibility not only of alleviating pain but also improving attention and mobility in the many older adults who have chronic multisite pain. This proposed full-size randomized controlled Tai Chi trial is a direct extension of the investigators' previous work examining chronic pain, attention demands, mobility and falls in the older population, and is built on the investigators' National Institute on Aging-supported Tai Chi feasibility and acceptability pilot studies among older adults with multisite pain and risk for falls. The goal of this single-blinded randomized controlled trial is to examine the effects of a 24-week Tai Chi intervention on chronic pain, cognition, mobility, fear of falling, and fall rate in older adults with multisite pain and at risk for falls. The results of this study will provide a foundation to establish the clinical significance of Tai Chi in the management of chronic multisite pain and to explore the mechanisms through which Tai Chi improves chronic pain symptoms and lowers fall rate in at-risk older adults.

Read the detailed description

The investigators will measure pain severity, pain interference, and fear of falling at baseline, mid-point (3-month), and post-intervention (6-month), as well as rate of falls during the intervention (0- to 6-month) and the 6-month follow-up period (month 6 to month 12) in 266 older adults (Tai Chi: N=133, and light physical exercise control: N=133). In addition, they will measure pain-related biomarkers, cognition, single-task and dual-task gait function, free-living physical activity, and sleep at baseline and post-intervention. The primary aims are: 1. to examine the effects of Tai Chi on pain symptoms in older adults with multisite pain. It is hypothesized that older adults in the Tai Chi intervention will have less pain, measured as pain severity and interference, than those in the light physical exercise control group; 2. to examine the effects of Tai Chi on fear of falling and rate of falls in older adults with multisite pain. It is hypothesized that older adults in the Tai Chi intervention will have less fear of falling and fewer falls than those in the light physical exercise control group. The secondary/exploratory aims are: 3. to examine the effects of Tai Chi on pain-related biomarkers in older adults with multisite pain. It is hypothesized that Tai Chi intervention will have greater reductions in levels of pain-related biomarkers and and beta endorphin, than those in the light physical exercise control group; 4. to examine the roles of changes in pain symptoms in the change of fall rate by Tai Chi in older adults with multisite pain. It is hypothesized that the effect of Tai Chi on the reduced fall rate will be explained in part by improvements in pain symptoms in older adults with multisite pain; 5. to examine the roles of changes in cognition and cognitive motor function in the change of fall rate by Tai Chi in older adults with multisite pain. It is hypothesized that the reduced fall rate in the Tai Chi group will be mediated by changes in cognition and cognitive-motor function in older adults with multisite pain.

02

Conditions studied

  • Chronic Pain
  • Falls

Browse trials for

Keywords

  • Tai Chi
  • Chronic Pain
  • Falls
  • Older Adults
03

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. be 65 years or older
  2. report chronic multisite (≥2 sites) musculoskeletal pain
  3. have had 1 or more falls in the past year or current use of an assistive device (a cane or walker)
  4. be able to walk 20 feet without help
  5. be able to communicate in English

Exclusion criteria

Exclusion Criteria:

  1. actively engage in moderate to vigorous exercise for more than 40 min/week
  2. practiced Tai Chi or other mind-body exercise within the past year, or practiced Tai Chi or other mind-body exercise regularly for at least 3 months within the past 5 years
  3. have cognitive impairment consistent with dementia (Montreal Cognitive Assessment (MOCA) score \< 18 after corrections),
  4. have a diagnosis of a disease/condition that would interfere with their study participation (e.g., rheumatoid arthritis, stroke, Parkinson's disease, degenerative neuromuscular disease, unstable cardiac disease, Alzheimer's disease or other dementia, terminal disease)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
266 participants (estimated)

Study arms

  • Placebo comparator
    Light physical exercise

    Usual-pace walking, strength exercise, stretching exercise, and balance exercise.

    Behavioral: Light physical exercise

  • Active comparator
    Tai Chi

    Tai Chi walking drills and Yang-style Tai Chi 8 forms.

    Behavioral: Tai Chi

Interventions

  • BehavioralLight physical exercise

    One hour each session, two sessions each week, for 6 months. Each session will be structured into three 15-minute segments (including warm-up activities/balance exercise/walking, upper and lower body strength exercise/walking, and stretching exercise/balance exercise/walking, respectively), each ending with a short break to record the Borg Rating of Perceived Exertion (RPE), followed by a 5-minute break time or cool-down/wrap-up session. The session will be taught by a certified exercise physiologist and a research assistant.

  • BehavioralTai Chi

    One hour each session, two sessions each week, for 6 months. Each session will be structured into three 15-minute segments (including warm-up activities/balance exercise/breathing exercise, Tai Chi walking drills, and Tai Chi 8-form, respectively), each ending with a short break to record the RPE, and followed by a 5-minute break or cool-down/wrap-up session. The session will be taught by an experienced Tai Chi instructor and a research assistant.

05

What researchers measure

Primary outcomes

  1. Pain severity

    Pain severity will be assessed using the Brief Pain Inventory.

    Time frame: 6 months

  2. Pain interference

    Pain interference will be assessed using the Brief Pain Inventory.

    Time frame: 6 months

  3. Fear of falling

    Fear of falling will be assessed using the Tinetti Falls Efficacy Scale.

    Time frame: 6 months

  4. Rate of falls

    Rate of falls will be assessed using monthly falls calendar postcards.

    Time frame: 12 months

Secondary outcomes

  1. C-reactive protein

    Plasma levels of C-reactive protein will be measured using enzyme-linked immunosorbent assays.

    Time frame: 6 months

  2. Interleukin 6

    Plasma levels of interleukin 6 will be measured using enzyme-linked immunosorbent assays.

    Time frame: 6 months

  3. Tumor necrosis factor alpha

    Plasma levels of tumor necrosis factor alpha will be measured using enzyme-linked immunosorbent assays.

    Time frame: 6 months

  4. Nuclear factor kappa B

    Plasma levels of nuclear factor kappa B will be measured using enzyme-linked immunosorbent assays.

    Time frame: 6 months

  5. Beta endorphin

    Plasma levels of beta endorphin will be measured using an enzyme-linked immunosorbent assay.

    Time frame: 6 months

  6. Attention

    Attention will be assessed by using 4 subscales of the Test of Everyday Attention.

    Time frame: 6 months

  7. Executive function

    Executive function will be assessed using the Trailmaking test, which requires the connection of sequentially numbered circles (part A), and the connection of circles marked by numbers and letters in alternating sequence (part B).

    Time frame: 6 months

  8. Physical Function

    Physical function will be measured by the well-validated Short Physical Performance Battery (SPPB), a composite measure of mobility including standing balance, usual-paced 4-meter walk, and time needed for 5 repeated chair stands performed without using arms.

    Time frame: 6 months

  9. Single-task stride time

    Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. The mat measures location and timing of individual steps, which then can be used to calculate stride time.

    Time frame: 6 months

  10. Single-task stride length

    Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. The mat measures location and timing of individual steps, which then can be used to calculate stride length.

    Time frame: 6 months

  11. Single-task swing time

    Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. The mat measures location and timing of individual steps, which then can be used to calculate swing time.

    Time frame: 6 months

  12. Dual-task stride length

    Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. During the dual-task walking, the participants will perform 2 sets of cognitive challenges in random order: serial subtractions 3 and 5 from 100. The mat measures location and timing of individual steps, which then can be used to calculate stride length.

    Time frame: 6 months

  13. Dual-task stride time

    Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. During the dual-task walking, the participants will perform 2 sets of cognitive challenges in random order: serial subtractions 3 and 5 from 100. The mat measures location and timing of individual steps, which then can be used to calculate stride time.

    Time frame: 6 months

  14. Free-living physical activity

    Participants will be instructed to wear an accelerometer (GT3X+, ActiGraph, LLC) on their non-dominant wrist for 7 days. The manufacturer's software, ActiLife, will be used to process data. Physical activity counts (per minute per day over the 7 days) will be used as a measure of total physical activity.

    Time frame: 6 months

  15. Dual-task swing time

    Gait will be assessed using a sensored gait mat that has embedded pressure sensors distributed throughout the mat. During the dual-task walking, the participants will perform 2 sets of cognitive challenges in random order: serial subtractions 3 and 5 from 100. The mat measures location and timing of individual steps, which then can be used to calculate swing time.

    Time frame: 6 months

  16. Sleep time

    Participants will be instructed to wear an accelerometer (GT3X+, ActiGraph, LLC) on their non-dominant wrist for 7 days. The manufacturer's software, ActiLife, will be used to process data to calculate total daily sleep time.

    Time frame: 6 months

  17. Sleep efficiency

    Participants will be instructed to wear an accelerometer (GT3X+, ActiGraph, LLC) on their non-dominant wrist for 7 days. The manufacturer's software, ActiLife, will be used to process data to calculate percent sleep during in-bed intervals (sleep efficiency).

    Time frame: 6 months

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03705598
Lead sponsor
University of Massachusetts, Boston
Collaborators
Brigham and Women's Hospital, Beth Israel Deaconess Medical Center
Responsible party
Tongjian You (Professor, University of Massachusetts, Boston) — Principal investigator
First posted
Oct 15, 2018
Start date
Sep 1, 2026 (estimated)
Primary completion
Apr 30, 2030 (estimated)
Completion
Jul 31, 2030 (estimated)
Last update
Aug 6, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion